BioFocus DPI is launching a new approach to discovery biology at the Society for Biomolecular Sciences Annual Conference taking place this week in St. Louis. Called ‘Intelligent Screening’, this approach focuses on combining the know-how and expertise of BioFocus DPI’s scientists with extensive high-throughput and information-rich screening capabilities to generate faster results and accelerate partners’ drug discovery programs.

According to Dr. Katherine Hilyard, Vice President of Biological Sciences at BioFocus DPI, “As the name Intelligent Screening implies, we are promoting an intelligence-led approach to discovery biology. This means harnessing our considerable screening experience within a wide range of target classes and disease areas to develop customized, biologically-relevant assays for partners’ discovery programs. This is in contrast with alternative approaches such as running numerous high-volume, high-throughput tests where the likelihood of identifying compounds with the desired biological activity is low.”

In shaping its Intelligent Screening approach, BioFocus DPI calls upon: PrimePathTM, its compound screening service that uses disease-relevant complex assays in human primary cells; its high-throughput and information-rich ion channel screening capabilities; and its natural product screening platform, which is ideal for addressing difficult targets, such as protein-protein interactions. Furthermore, these services are complemented by BioFocus DPI’s world-class screening libraries.

More information about using this Intelligent Screening approach in hit finding, hit-to-lead and lead optimization campaigns can be found at www.biofocusdpi.com.

About BioFocus

DPI BioFocus DPI’s aim is to expand partners’ drug pipeline by accelerating the gene-to-candidate discovery process. This is achieved through a comprehensive discovery platform, which includes target discovery in human primary cells, focused as well as diverse compound libraries, in vitro and cell-based screening, medicinal chemistry and ADME/PK services, supported by unique chemogenomic and informatics tools. As the service division of Galapagos, BioFocus DPI has over 300 employees in five countries worldwide.